Cargando…

Performance of an Automated Insulin Delivery System: Results of Early Phase Feasibility Studies

Background: Automated insulin delivery (AID) systems have demonstrated improvements in time-in-range (TIR, blood glucose 70–180 mg/dL) without increasing hypoglycemia. Testing a closed-loop system in an inpatient environment with supervised challenges allows for initial evaluation of performance and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christiansen, Mark, Bartee, Amy, Lalonde, Amy, Jones, Richard E., Katz, Michelle, Wolpert, Howard, Brazg, Ronald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906863/ https://www.ncbi.nlm.nih.gov/pubmed/32940537 http://dx.doi.org/10.1089/dia.2020.0318

Ejemplares similares

Predictive Low-Glucose Suspend Necessitates Less Carbohydrate Supplementation to Rescue Hypoglycemia: Need to Revisit Current Hypoglycemia Treatment Guidelines
por: Pinsker, Jordan E., et al.
Publicado: (2021)

Feasibility of automated insulin delivery guided by continuous glucose monitoring in preterm infants
por: Beardsall, Kathryn, et al.
Publicado: (2020)

Open source automated insulin delivery: addressing the challenge
por: Oliver, Nick, et al.
Publicado: (2019)

AID(„automated insulin delivery“)-Systeme in der Diabetologie
por: Biester, Torben, et al.
Publicado: (2021)

Feasibility of Outpatient 24-Hour Closed-Loop Insulin Delivery
por: de Bock, Martin I., et al.
Publicado: (2015)

A scoping review of Do-It-Yourself Automated Insulin Delivery system (DIY AID) use in people with type 1 diabetes
por: Morrison, Amy E., et al.
Publicado: (2022)

Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen
por: Bergenstal, Richard M., et al.
Publicado: (2019)

A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study
por: Christiansen, Mark P., et al.
Publicado: (2019)

Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice
por: Phillip, Moshe, et al.
Publicado: (2022)

Automated Insulin Delivery: Easy Enough to Use in Primary Care?
por: Heile, Michael, et al.
Publicado: (2020)

Intelligent Control with Artificial Neural Networks for Automated Insulin Delivery Systems
por: de Farias, João Lucas Correia Barbosa, et al.
Publicado: (2022)

The changing landscape of automated insulin delivery in the management of type 1 diabetes
por: Lakshman, Rama, et al.
Publicado: (2023)

Swimming With the Omnipod 5 Automated Insulin Delivery System: Connectivity in the Water
por: Hughes, Michael S., et al.
Publicado: (2023)

Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm, Feasibility Trial
por: Davis, Georgia M., et al.
Publicado: (2023)

Safety and Performance of the Tandem t:slim X2 with Control-IQ Automated Insulin Delivery System in Toddlers and Preschoolers
por: Ekhlaspour, Laya, et al.
Publicado: (2021)

What End Users and Stakeholders Want From Automated Insulin Delivery Systems
por: Naranjo, Diana, et al.
Publicado: (2017)

The Psychological Implications of Automated Insulin Delivery Systems in Type 1 Diabetes Care
por: Nefs, Giesje
Publicado: (2022)

Response to Comment on: Wolpert et al. Dietary Fat Acutely Increases Glucose Concentrations and Insulin Requirements in Patients With Type 1 Diabetes: Implications for Carbohydrate-Based Bolus Dose Calculation and Intensive Diabetes Management. Diabetes Care 2013;36:810–816
por: Wolpert, Howard A.
Publicado: (2013)

Practical aspects of diabetes technology use: Continuous glucose monitors, insulin pumps, and automated insulin delivery systems
por: Marks, Brynn E., et al.
Publicado: (2021)

FRI654 Concentrated Regular U-500 Insulin In An Automated Insulin Delivery System: A Case Report
por: Aurora, John, et al.
Publicado: (2023)

Primary care delivery of behavioral weight loss services for adults with cardiovascular risk factors: development of pragmatic implementation strategies and results of a randomized feasibility trial
por: Ackermann, Ronald T, et al.
Publicado: (2023)

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes
por: Garg, Satish K., et al.
Publicado: (2017)

Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study
por: Jones, Laney K., et al.
Publicado: (2021)

Automated Insulin Delivery with SGLT2i Combination Therapy in Type 1 Diabetes
por: Garcia-Tirado, Jose, et al.
Publicado: (2022)

A Systematic Review of Commercial Hybrid Closed-Loop Automated Insulin Delivery Systems
por: Peacock, Sofia, et al.
Publicado: (2023)

Primary care delivery of behavioral weight loss services for adults with cardiovascular risk factors: development of pragmatic practice components and results of a randomized feasibility trial
por: Ackermann, Ronald T., et al.
Publicado: (2023)

Continuous delivery for mobile with fastlane: automating mobile application development and deployment for iOS and Android
por: Katz, Doron
Publicado: (2018)

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
por: Brown, Sue A., et al.
Publicado: (2021)

Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits
por: Pauley, Meghan E., et al.
Publicado: (2022)

Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines
por: Peters, Anne L, et al.
Publicado: (2018)

Assessing patient‐reported outcomes for automated insulin delivery systems: the psychometric properties of the INSPIRE measures
por: Weissberg‐Benchell, J., et al.
Publicado: (2019)

Zone-MPC Automated Insulin Delivery Algorithm Tuned for Pregnancy Complicated by Type 1 Diabetes
por: Ozaslan, Basak, et al.
Publicado: (2022)

Review of Automated Insulin Delivery Systems for Type 1 Diabetes and Associated Time in Range Outcomes
por: Nallicheri, Armaan, et al.
Publicado: (2022)

Practical Aspects and Exercise Safety Benefits of Automated Insulin Delivery Systems in Type 1 Diabetes
por: Zaharieva, Dessi P., et al.
Publicado: (2023)

Assessment of Meal Anticipation for Improving Fully Automated Insulin Delivery in Adults With Type 1 Diabetes
por: Garcia-Tirado, Jose, et al.
Publicado: (2023)

Central Venous Catheter-directed Tissue Plasminogen Activator in Massive Pulmonary Embolism
por: Gulati, Vishal, et al.
Publicado: (2018)

Safety Evaluation of the Omnipod® 5 Automated Insulin Delivery System Over Three Months of Use in Children With Type 1 Diabetes (T1D)
por: Buckingham, Bruce A, et al.
Publicado: (2021)

Closed-Loop Insulin Delivery Using a Subcutaneous Glucose Sensor and Intraperitoneal Insulin Delivery: Feasibility study testing a new model for the artificial pancreas
por: Renard, Eric, et al.
Publicado: (2010)

User experiences during the transition to calibration-free sensors with remote monitoring while using automated insulin delivery - a qualitative study
por: Sehgal, Shekhar, et al.
Publicado: (2023)

Interviews with Indigenous Māori with type 1 diabetes using open-source automated insulin delivery in the CREATE randomised trial
por: Burnside, Mercedes, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rgekfpiob59q3nmfk6tj7u6co0